News
2d
Zacks Investment Research on MSNWerewolf Therapeutics (HOWL) Upgraded to Buy: Here's What You Should KnowInvestors might want to bet on Werewolf Therapeutics, Inc. (HOWL), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...
California wildlife officials confirmed three new wolf packs in Northern California, bringing the state total to 10.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Werewolf Therapeutics Price Performance Shares of NASDAQ:HOWL opened at $0.90 on Thursday. The stock has a market cap of $40.45 million, a PE ratio of -0.59 and a beta of 0.48. The company’s ...
The latest price target for Werewolf Therapeutics (NASDAQ:HOWL) was reported by Wedbush on May 9, 2025. The analyst firm set a price target for $6.00 expecting HOWL to rise to within 12 months (a ...
Investors might want to bet on Werewolf Therapeutics, Inc. (HOWL), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results